{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T22:18:02Z","timestamp":1792016282362,"version":"4.4.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2020,4,27]],"date-time":"2020-04-27T00:00:00Z","timestamp":1587945600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,4,27]],"date-time":"2020-04-27T00:00:00Z","timestamp":1587945600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1007\/s00259-020-04785-z","type":"journal-article","created":{"date-parts":[[2020,4,26]],"date-time":"2020-04-26T21:02:21Z","timestamp":1587934941000},"page":"2901-2910","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":39,"title":["Differential diagnosis of parkinsonian syndromes: a comparison of clinical and automated - metabolic brain patterns\u2019 based approach"],"prefix":"10.1007","volume":"47","author":[{"given":"Toma\u017e","family":"Rus","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra","family":"Tom\u0161e","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luka","family":"Jensterle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marko","family":"Grmek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zvezdan","family":"Pirto\u0161ek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Eidelberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maja","family":"Tro\u0161t","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,4,27]]},"reference":[{"key":"4785_CR1","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1002\/mds.26424","volume":"30","author":"RB Postuma","year":"2015","unstructured":"Postuma RB, Berg D, Stern M, Poewe W, Olanow CW, Oertel W, et al. MDS clinical diagnostic criteria for Parkinson\u2019s disease. Mov Disord. 2015;30:1591\u2013601.","journal-title":"Mov Disord"},{"key":"4785_CR2","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.ncl.2014.09.012","volume":"33","author":"M Stamelou","year":"2015","unstructured":"Stamelou M, Bhatia KP. A typical parkinsonism diagnosis and treatment. Neurol Clin Elsevier Inc. 2015;33:39\u201356.","journal-title":"Neurol Clin Elsevier Inc"},{"key":"4785_CR3","doi-asserted-by":"crossref","unstructured":"Dickson DW. Parkinson\u2019s disease and parkinsonism: neuropathology. Cold Spring Harb Perspect Med. Cold Spring Harbor Laboratory Press; 2012;2.","DOI":"10.1101\/cshperspect.a009258"},{"key":"4785_CR4","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1212\/WNL.0000000000000641","volume":"83","author":"CH Adler","year":"2014","unstructured":"Adler CH, Beach TG, Hentz JG, Shill HA, Caviness JN, Driver-Dunckley E, et al. Low clinical diagnostic accuracy of early vs advanced Parkinson disease: clinicopathologic study. Neurology. 2014;83:406\u201312.","journal-title":"Neurology."},{"key":"4785_CR5","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1016\/j.parkreldis.2014.04.019","volume":"20","author":"J Joutsa","year":"2014","unstructured":"Joutsa J, Gardberg M, R\u00f6ytt\u00e4 M, Kaasinen V. Diagnostic accuracy of parkinsonism syndromes by general neurologists. Parkinsonism Relat Disord. 2014;20:840\u20134.","journal-title":"Parkinsonism Relat Disord"},{"key":"4785_CR6","doi-asserted-by":"publisher","first-page":"2244","DOI":"10.1007\/s00259-016-3464-8","volume":"43","author":"F Niccolini","year":"2016","unstructured":"Niccolini F, Politis M. A systematic review of lessons learned from PET molecular imaging research in atypical parkinsonism. Eur J Nucl Med Mol Imaging. 2016;43:2244\u201354.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"4785_CR7","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1212\/WNL.0b013e31826c1b0a","volume":"79","author":"S Hellwig","year":"2012","unstructured":"Hellwig S, Amtage F, Kreft A, Buchert R, Winz OH, Vach W, et al. [18F]FDG-PET is superior to [123I]IBZM-SPECT for the differential diagnosis of parkinsonism. Neurology. 2012;79:1314\u201322.","journal-title":"Neurology."},{"key":"4785_CR8","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1007\/s00234-012-1132-7","volume":"55","author":"M Tripathi","year":"2013","unstructured":"Tripathi M, Dhawan V, Peng S, Kushwaha S, Batla A, Jaimini A, et al. Differential diagnosis of parkinsonian syndromes using F-18 fluorodeoxyglucose positron emission tomography. Neuroradiology. 2013;55:483\u201392.","journal-title":"Neuroradiology."},{"key":"4785_CR9","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/S0720-048X(03)00214-6","volume":"51","author":"R Juh","year":"2004","unstructured":"Juh R, Kim J, Moon D, Choe B, Suh T. Different metabolic patterns analysis of parkinsonism on the18F-FDG PET. Eur J Radiol. 2004;51:223\u201333.","journal-title":"Eur J Radiol"},{"key":"4785_CR10","first-page":"1834","volume":"130","author":"C Huang","year":"2007","unstructured":"Huang C, Tang C, Feigin A, Lesser M, Ma Y, Pourfar M, et al. Changes in network activity with the progression of Parkinson\u2019s disease. Brain Oxford University Press. 2007;130:1834\u201346.","journal-title":"Brain Oxford University Press"},{"key":"4785_CR11","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1111\/ene.13269","volume":"24","author":"SP Caminiti","year":"2017","unstructured":"Caminiti SP, Alongi P, Majno L, Volont\u00e8 MA, Cerami C, Gianolli L, et al. Evaluation of an optimized [ 18 F]fluoro-deoxy-glucose positron emission tomography voxel-wise method to early support differential diagnosis in atypical Parkinsonian disorders. Eur J Neurol. 2017;24:687\u2013e26.","journal-title":"Eur J Neurol"},{"key":"4785_CR12","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1016\/j.neuroimage.2008.12.063","volume":"45","author":"PG Spetsieris","year":"2009","unstructured":"Spetsieris PG, Ma Y, Dhawan V, Eidelberg D. Differential diagnosis of parkinsonian syndromes using PCA-based functional imaging features. Neuroimage. 2009;45:1241\u201352.","journal-title":"Neuroimage."},{"key":"4785_CR13","doi-asserted-by":"publisher","first-page":"2899","DOI":"10.1016\/j.neuroimage.2010.10.025","volume":"54","author":"PG Spetsieris","year":"2011","unstructured":"Spetsieris PG, Eidelberg D. Scaled subprofile modeling of resting state imaging data in Parkinson\u2019s disease: methodological issues. Neuroimage. 2011;54:2899\u2013914.","journal-title":"Neuroimage."},{"key":"4785_CR14","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1038\/sj.jcbfm.9600358","volume":"27","author":"Y Ma","year":"2007","unstructured":"Ma Y, Tang C, Spetsieris PG, Dhawan V, Eidelberg D. Abnormal metabolic network activity in Parkinson\u2019s disease: test\u2014retest reproducibility. J Cereb Blood Flow Metab. 2007;27:597\u2013605.","journal-title":"J Cereb Blood Flow Metab"},{"key":"4785_CR15","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1016\/j.parkreldis.2013.02.013","volume":"19","author":"P Wu","year":"2013","unstructured":"Wu P, Wang J, Peng S, Ma Y, Zhang H, Guan Y, et al. Metabolic brain network in the Chinese patients with Parkinson\u2019s disease based on 18F-FDG PET imaging. Parkinsonism Relat Disord. 2013;19:622\u20137.","journal-title":"Parkinsonism Relat Disord"},{"key":"4785_CR16","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1002\/mds.25361","volume":"28","author":"LK Teune","year":"2013","unstructured":"Teune LK, Renken RJ, Mudali D, De Jong BM, Dierckx RA, Roerdink JBTM, et al. Validation of parkinsonian disease-related metabolic brain patterns. Mov Disord. 2013;28:547\u201351.","journal-title":"Mov Disord"},{"key":"4785_CR17","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1007\/s00234-017-1821-3","volume":"59","author":"P Tom\u0161e","year":"2017","unstructured":"Tom\u0161e P, Jensterle L, Grmek M, Zaletel K, Pirto\u0161ek Z, Dhawan V, et al. Abnormal metabolic brain network associated with Parkinson\u2019s disease: replication on a new European sample. Neuroradiology. 2017;59:507\u201315.","journal-title":"Neuroradiology."},{"key":"4785_CR18","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1002\/mds.21933","volume":"23","author":"T Eckert","year":"2008","unstructured":"Eckert T, Tang C, Ma Y, Brown N, Lin T, Frucht S, et al. Abnormal metabolic networks in atypical parkinsonism. Mov Disord. 2008;23:727\u201333.","journal-title":"Mov Disord"},{"key":"4785_CR19","doi-asserted-by":"publisher","first-page":"3036","DOI":"10.1093\/brain\/awu256","volume":"137","author":"M Niethammer","year":"2014","unstructured":"Niethammer M, Tang CC, Feigin A, Allen PJ, Heinen L, Hellwig S, et al. A disease-specific metabolic brain network associated with corticobasal degeneration. Brain. 2014;137:3036\u201346.","journal-title":"Brain."},{"key":"4785_CR20","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/S1474-4422(10)70002-8","volume":"9","author":"CC Tang","year":"2010","unstructured":"Tang CC, Poston KL, Eckert T, Feigin A, Frucht S, Gudesblatt M, et al. Differential diagnosis of parkinsonism: a metabolic imaging study using pattern analysis. Lancet Neurol. 2010;9:149\u201358.","journal-title":"Lancet Neurol"},{"key":"4785_CR21","doi-asserted-by":"publisher","first-page":"60","DOI":"10.2967\/jnumed.115.161992","volume":"57","author":"M Tripathi","year":"2016","unstructured":"Tripathi M, Tang CCC, Feigin A, De Lucia I, Nazem A, Dhawan V, et al. Automated differential diagnosis of early parkinsonism using metabolic brain networks: a validation study. J Nucl Med. 2016;57:60\u20136.","journal-title":"J Nucl Med"},{"key":"4785_CR22","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1136\/jnnp.55.3.181","volume":"55","author":"AJ Hughes","year":"1992","unstructured":"Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson\u2019s disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry. 1992;55:181\u20134.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"4785_CR23","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1212\/01.wnl.0000324625.00404.15","volume":"71","author":"S Gilman","year":"2008","unstructured":"Gilman S, Wenning GK, Low PA, Brooks DJ, Mathias CJ, Trojanowski JQ, et al. Second consensus statement on the diagnosis of multiple system atrophy. Neurology. 2008;71:670\u20136.","journal-title":"Neurology."},{"key":"4785_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1212\/WNL.47.1.1","volume":"47","author":"I Litvan","year":"1996","unstructured":"Litvan I, Agid Y, Calne D, Campbell G, Dubois B, Duvoisin RC, et al. Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop. Neurology. 1996;47:1\u20139.","journal-title":"Neurology."},{"key":"4785_CR25","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1002\/mds.26987","volume":"32","author":"GU H\u00f6glinger","year":"2017","unstructured":"H\u00f6glinger GU, Respondek G, Stamelou M, Kurz C, Josephs KA, Lang AE, et al. Clinical diagnosis of progressive supranuclear palsy: the movement disorder society criteria. Mov Disord. 2017;32:853\u201364.","journal-title":"Mov Disord"},{"key":"4785_CR26","doi-asserted-by":"publisher","first-page":"a033118","DOI":"10.1101\/cshperspect.a033118","volume":"10","author":"MG Erkkinen","year":"2018","unstructured":"Erkkinen MG, Kim M-O, Geschwind MD. Clinical neurology and epidemiology of the major neurodegenerative diseases. Cold Spring Harb Perspect Biol. 2018;10:a033118.","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"4785_CR27","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1177\/0271678X16637880","volume":"37","author":"JH Ko","year":"2017","unstructured":"Ko JH, Lee CS, Eidelberg D. Metabolic network expression in parkinsonism: clinical and dopaminergic correlations. J Cereb Blood Flow Metab. 2017;37:683\u201393.","journal-title":"J Cereb Blood Flow Metab"},{"key":"4785_CR28","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1002\/mds.27485","volume":"33","author":"TG Beach","year":"2018","unstructured":"Beach TG, Adler CH. Importance of low diagnostic accuracy for early Parkinson\u2019s disease. Mov Disord. 2018;33:1551\u20134.","journal-title":"Mov Disord"},{"key":"4785_CR29","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1093\/brain\/awf080","volume":"125","author":"AJ Hughes","year":"2002","unstructured":"Hughes AJ, Daniel SE, Ben-Shlomo Y, Lees AJ. The accuracy of diagnosis of parkinsonian syndromes in a specialist movement disorder service. Brain. 2002;125:861\u201370.","journal-title":"Brain."},{"key":"4785_CR30","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.parkreldis.2016.05.015","volume":"29","author":"A Merola","year":"2016","unstructured":"Merola A, Espay AJ, Romagnolo A, Bernardini A, Rizzi L, Rosso M, et al. Advanced therapies in Parkinson\u2019s disease: long-term retrospective study. Parkinsonism Relat Disord. 2016;29:104\u20138.","journal-title":"Parkinsonism Relat Disord"},{"key":"4785_CR31","doi-asserted-by":"publisher","first-page":"2149","DOI":"10.1002\/mds.21648","volume":"22","author":"LC Shih","year":"2007","unstructured":"Shih LC, Tarsy D. Deep brain stimulation for the treatment of atypical parkinsonism. Mov Disord. 2007;22:2149\u201355.","journal-title":"Mov Disord"},{"key":"4785_CR32","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/S1474-4422(18)30169-8","volume":"17","author":"KA Schindlbeck","year":"2018","unstructured":"Schindlbeck KA, Eidelberg D. Network imaging biomarkers: insights and clinical applications in Parkinson\u2019s disease. Lancet Neurol. 2018;17:629\u201340.","journal-title":"Lancet Neurol"},{"key":"4785_CR33","doi-asserted-by":"crossref","unstructured":"Wenning GK, Scherfler C, Granata R, B\u00f6sch S, Verny M, Chaudhuri KR, et al. Time course of symptomatic orthostatic hypotension and urinary incontinence in patients with postmortem confirmed parkinsonian syndromes: a clinicopathological study. J Neurol Neurosurg Psychiatry. BMJ Publishing Group; 1999;67:620\u2013623.","DOI":"10.1136\/jnnp.67.5.620"},{"key":"4785_CR34","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1016\/j.sleep.2012.10.015","volume":"14","author":"BF Boeve","year":"2013","unstructured":"Boeve BF, Silber MH, Ferman TJ, Lin SC, Benarroch EE, Schmeichel AM, et al. Clinicopathologic correlations in 172 cases of rapid eye movement sleep behavior disorder with or without a coexisting neurologic disorder. Sleep Med. 2013;14:754\u201362.","journal-title":"Sleep Med"},{"key":"4785_CR35","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.ejmp.2017.01.018","volume":"41","author":"P Tom\u0161e","year":"2017","unstructured":"Tom\u0161e P, Jensterle L, Rep S, Grmek M, Zaletel K, Eidelberg D, et al. The effect of 18F-FDG-PET image reconstruction algorithms on the expression of characteristic metabolic brain network in Parkinson\u2019s disease. Phys Med. 2017;41:129\u201335.","journal-title":"Phys Med"},{"key":"4785_CR36","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.ejmp.2018.06.637","volume":"52","author":"P Tom\u0161e","year":"2018","unstructured":"Tom\u0161e P, Peng S, Pirto\u0161ek Z, Zaletel K, Dhawan V, Eidelberg D, et al. The effects of image reconstruction algorithms on topographic characteristics, diagnostic performance and clinical correlation of metabolic brain networks in Parkinson\u2019s disease. Phys Medica. 2018;52:104\u201312.","journal-title":"Phys Medica"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-020-04785-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00259-020-04785-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-020-04785-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,7]],"date-time":"2021-10-07T08:31:35Z","timestamp":1633595495000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00259-020-04785-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,27]]},"references-count":36,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["4785"],"URL":"https:\/\/doi.org\/10.1007\/s00259-020-04785-z","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,27]]},"assertion":[{"value":"16 November 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"DE serves as a member of scientific advisory board of Ovid Therapeutics (receives personal fees) and has served on the scientific advisory board of The Michael J. Fox Foundation (has received honoraria); is a consultant to MeiraGTx (has received fees); is listed as coinventor of patents for markers for use in screening patients for nervous system dysfunction as well as a method and apparatus for using same (without financial gain); has received research support from the National Institutes of Health (NINDS, NIAID) and The Michael J. Fox Foundation for Parkinson\u2019s Research. The other authors have no relevant conflicts of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Written informed consent was obtained from the participating subjects.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"All procedures performed in the study involving human participants were in accordance with the ethical standards of the national research committee (The National Medical Ethics Committee of the Republic of Slovenia, 0120-351\/2015-2, KME 70\/07\/15) and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}